Cargando…

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure

BACKGROUND AND OBJECTIVES: Inflammasomes are involved in the pathogenesis of different neuroimmune and neurodegenerative diseases, including multiple sclerosis (MS). In a previous study by our group, the nucleotide-binding oligomerization domain, leucine-rich repeat receptor and pyrin-domain–contain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malhotra, Sunny, Hurtado-Navarro, Laura, Pappolla, Agustin, Villar, Luisa M. M., Río, Jordi, Montalban, Xavier, Pelegrin, Pablo, Comabella, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042441/ https://www.ncbi.nlm.nih.gov/pubmed/36973075 http://dx.doi.org/10.1212/NXI.0000000000200100

Ejemplares similares

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers
por: Hurtado-Navarro, Laura, et al.
Publicado: (2022)

Liquid Biopsy in Neurological Diseases
por: Malhotra, Sunny, et al.
Publicado: (2023)

Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation
por: Lucas-Ruiz, Fernando, et al.
Publicado: (2022)

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
por: Malhotra, Sunny, et al.
Publicado: (2018)

Emerging Role of the Inflammasome and Pyroptosis in Hypertension
por: De Miguel, Carmen, et al.
Publicado: (2021)

Pyroptosis in NLRP3 inflammasome-related atherosclerosis
por: Zeng, Xiang, et al.
Publicado: (2022)

Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta
por: Bustamante, Marta F., et al.
Publicado: (2013)

Viral Glycoproteins Induce NLRP3 Inflammasome Activation and Pyroptosis in Macrophages
por: Eisfeld, Hannah S., et al.
Publicado: (2021)

Brain volume loss and physical and cognitive impairment in naïve multiple sclerosis patients treated with fingolimod: prospective cohort study in Buenos Aires, Argentina
por: Rojas, Juan Ignacio, et al.
Publicado: (2022)

Lytic cell death induced by melittin bypasses pyroptosis but induces NLRP3 inflammasome activation and IL-1β release
por: Martín-Sánchez, Fátima, et al.
Publicado: (2017)

The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases
por: de Torre-Minguela, Carlos, et al.
Publicado: (2017)

Emerging Role of NLRP3 Inflammasome/Pyroptosis in Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2022)

NLRP3 inflammasome-induced pyroptosis in digestive system tumors
por: Wen, Jiexia, et al.
Publicado: (2023)

Search for Specific Biomarkers of IFNβ Bioactivity in Patients with Multiple Sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2011)

The NLRP1 Inflammasome Induces Pyroptosis in Human Corneal Epithelial Cells
por: Griswold, Andrew R., et al.
Publicado: (2022)

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
por: Zheng, Xiaoqin, et al.
Publicado: (2023)

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
por: Camacho-Toledano, Celia, et al.
Publicado: (2022)

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2015)

Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms
por: Comabella, Manuel, et al.
Publicado: (2008)

Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype
por: Sallman, David A., et al.
Publicado: (2016)

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
por: Cai, Yawen, et al.
Publicado: (2022)

NLRP3 inflammasome activation mediates sleep deprivation-induced pyroptosis in mice
por: Fan, Kun, et al.
Publicado: (2021)

Chloride sensing by WNK1 regulates NLRP3 inflammasome activation and pyroptosis
por: Mayes-Hopfinger, Lindsey, et al.
Publicado: (2021)

NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
por: Zhang, Lixia, et al.
Publicado: (2022)

Aerobic exercise alleviates pyroptosis-related diseases by regulating NLRP3 inflammasome
por: Hu, Shujuan, et al.
Publicado: (2022)

Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
por: Bascuñana, Pablo, et al.
Publicado: (2020)

Role of NLRP3 inflammasome in systemic sclerosis
por: Lin, Cong, et al.
Publicado: (2022)

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
por: Zeng, Cheng, et al.
Publicado: (2020)

NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
por: Faria, Sara Socorro, et al.
Publicado: (2021)

Dieckol Attenuated Glucocorticoid-Induced Muscle Atrophy by Decreasing NLRP3 Inflammasome and Pyroptosis
por: Oh, Seyeon, et al.
Publicado: (2021)

Cochlear Marginal Cell Pyroptosis Is Induced by Cisplatin via NLRP3 Inflammasome Activation
por: Yu, Wenting, et al.
Publicado: (2022)

NLRP3 Inflammasome-Mediated Pyroptosis Pathway Contributes to the Pathogenesis of Candida albicans Keratitis
por: Lian, Huifang, et al.
Publicado: (2022)

Paeonol regulates NLRP3 inflammasomes and pyroptosis to alleviate spinal cord injury of rat
por: Zhao, Houling, et al.
Publicado: (2022)

Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation
por: Zhang, Lei, et al.
Publicado: (2022)

Puerarin ameliorates acute lung injury by modulating NLRP3 inflammasome-induced pyroptosis
por: Cai, Dasheng, et al.
Publicado: (2022)

Ischemic Preconditioning Provides Neuroprotection by Inhibiting NLRP3 Inflammasome Activation and Cell Pyroptosis
por: Gao, Li, et al.
Publicado: (2023)

Sorcin regulate pyroptosis by interacting with NLRP3 inflammasomes to facilitate the progression of hepatocellular carcinoma
por: Li, Zhenfen, et al.
Publicado: (2023)

Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation
por: Luo, Tianyu, et al.
Publicado: (2022)

Techniques to Study Inflammasome Activation and Inhibition by Small Molecules
por: Angosto-Bazarra, Diego, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2rcoiaiql5jfb69hppmnpc4vq0